Skip to content

Genetic and Biohumoral Factors Involved in Menière's Disease and Their Correlation With Phenotypes

Genetics and Biohumoral Factors in Menière's Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07518069
Acronym
Menière09
Enrollment
250
Registered
2026-04-08
Start date
2025-04-09
Completion date
2027-04-12
Last updated
2026-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meniere's Disease, Vertigo, Vestibular Migraine

Keywords

episodic vertigo, Menière's Disease, Vestibular migraine, genetics, biohumoral markers

Brief summary

Aim of this work was to assess the role of polymorphisms belonging to genes involved in the regulation of ionic homeostasis in Caucasian patients with Ménière Disease (MD) and compare results with a cohort of patients affected by vestibular migraine and a cohort of non vestibular subjects

Detailed description

Ménière's Disease (MD) is an inner ear disorder characterized by episodic vertigo, fluctuating sensorineural hearing loss and aural fullness \[1\]; endolymphatic hydrops is commonly associated with the pathophysiology of the disorder, although current data support the hypothesis that hydrops is an epiphenomenon associated with different inner ear disorders. The frequency of familial cases has been estimated in the range between 5 and 15% and it has been hypothesized that the disorder may arise from the interplay of genetic and environmental factors. Different candidate genes have been studied, although to date genetic investigation produced no conclusive results . Among others, considering the importance of ionic homeostasis in the inner ear for the maintenance of endocochlear potential, genetic of fluid and ionic homeostasis have been included. A mutation of KCNQ1 and KCNE1 channels, co-expressed in the inner ear and in the heart, leads to a severe sensorineural deafness and a collapse of the cochlear scala media as seen in Jervell and Lange-Nielsen syndrome. The aim of this work was to assess the role of genetic polymorphisms located in genes involved in the regulation of ionic transport on an Italian population of patients with definite MD.

Interventions

GENETICa blood withdrawal will be obtained

A blood withdrawal will be obtained to assess

GENETICblood withdrawal

Genetics of ionic transporters and biohumoral factors related to Meniere's Disease and differences with vestibular migraine subjects

Sponsors

IRCCS San Raffaele
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients with definite Menière's Disease according to the criteria of the Barany Society

Exclusion criteria

* surgically treated before the examination or if they had undergone intratympanic therapy with steroids or gentamicin

Design outcomes

Primary

MeasureTime frameDescription
Genetic of ionic transportersFrom enrollment to the end of enrollment in december 2027Genomic DNA of all cases and controls was extracted from venous blood by standard methods. 36 Single Nucleotide Polymorphisms (SNPs) were genotyped using TaqMan® OpenArray™ Genotyping System (Life Technologies, Foster City, CA). All DNA samples were loaded and amplified according to the manufacturer's instructions.

Secondary

MeasureTime frameDescription
Biohumoral factors specifically Interleukins, Endogenous OuabainFrom enrollment to the end of the study in july 2027Values of interleukins and endogenous ouabain is evaluated in blood sample of patients and compared with values in blood samples of a control group and in patients with vestibular migraine

Countries

Italy

Contacts

CONTACTRoberto Carlo Teggi, MD
teggi.roberto@hsr.it+393921569410
CONTACTLaura Zagato, MD
zagato.laura@hsr.it+393406133818

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 9, 2026